← Leaderboards
Jayne Sutherland
Stellenbosch University
$2,353,038
Attributed
$7,059,114
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,059,114 · 1
By mechanism
U01$7,059,114 · 1
Top collaborators
- John T Belisle5 shared
- Gerhard Walzl5 shared
Most similar at Stellenbosch University
Same institution · by research overlap
- John T Belisle$22,161,703
- James Alexander Seddon$4,133,107
- Gerhard Walzl$3,997,795
Others in their field
Other Emerging Leaders on “Diagnostic”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$293,634,608
- Lynn Briscoe · Leidos Biomedical Research, Inc.$100,239,656
- Leonard Freedmand · Leidos Biomedical Research, Inc.$63,918,621
- Mark Marino · Venturewell$61,502,138
- Scott Topper · Broad Institute, Inc.$51,811,587
Research focus
DiagnosticDiagnosisAdultAreaAsiaAfricaAffectBiosignatureBloodCaringCessation Of LifeChildClinical ResearchClinical Research SiteCohortCo-InfectionCommunitiesComorbidityComplementComplexCost EffectiveCountryDetectionDiagnostics Research
Grant awards (5)
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,059,114
U01 · FY2025 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2024 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2023 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2021 · AI
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)$1,500,000
U01 · FY2020 · AI